BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →

Loading DERM charts…

Search ticker or company⌘K

DERM

01Multicharts 02Comparables 03Price target

May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy

DERM · Journey Medical Corp fundamentals · vpside

vpside

⌘K

DERMMarket cap $142M/Last filing 10-Q, Q2 FY26 · 12 Aug 2026/DERMMarket cap $142M/Last filing 10-Q, Q2 FY26 · 12 Aug 2026/DERMMarket cap $142M/Last filing 10-Q, Q2 FY26 · 12 Aug 2026/DERMMarket cap $142M/Last filing 10-Q, Q2 FY26 · 12 Aug 2026/

Filings synced 13:22 · Prices: prior close 30 Oct

DERM

Journey Medical Corp

Nasdaq · Pharmaceutical preparations (SIC 2834) · FY ends 31 Dec

01Multicharts 02Comparables 03Price target

Add a metric37 metrics

Revenue, quarterly

$18M+18.9% year on year

$30M$20M$10M$0

vpside.com

Q1 ’22Q1 ’23Q2 ’24Q2 ’25Q2 ’26

Company filings · 10-Q filed 12 Aug 2026 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

69.3%+5.5 pp year on year

70%60%50%

vpside.com

Q4 ’22Q3 ’23Q2 ’24Q4 ’24Q3 ’25

Company filings · 10-Q filed 12 Nov 2025 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$26M+26.4% year on year

$60M$40M$20M$0

vpside.com

Q4 ’21Q1 ’23Q1 ’24Q2 ’25Q2 ’26

Company filings · 10-Q filed 12 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

$240000

$20M$0−$20M−$40M

vpside.com

Q4 ’22Q1 ’23Q2 ’23Q3 ’23Q4 ’23

Company filings · 10-K filed 27 Mar 2025 · TTM = last four quartersvpside.com

Chart 05 is empty

Chart 06 is empty

Fundamentals: company filings · Q4 = full year − nine months · TTM = last four quarters